Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 11, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 5, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record34421 flagged findings
Reported transactions (Form 4)80since Oct 18, 2024 · and 17 other holdings
Corporate events (8-K)17since May 18, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-11share offering or dilution eventrecentOpen filing ↗“…customer demand, management of growth, and the effectiveness of marketing by the Company. 5 Liquidity Through March 31,…”
+1 more passage from the same document
- “…stock, preferred stock, debt securities, warrants and units or any combination thereof. We also simultaneously entered into an Open…”
- 2026-05-11capital return (buybacks/dividends)recentOpen filing ↗“…pre-funded warrant was offered and sold at a price to the public of $ 5.99999 per pre-funded warrant. The Company received…”
+1 more passage from the same document
- “…raised substantial doubt about the Company’s ability to continue as a going concern, primarily due to recurring operating losses,…”
- 2026-05-05share offering or dilution eventrecentOpen filing ↗“…Prospectus Supplement (as defined below), to purchase up to an additional 6,508,650 shares of Common Stock (the “Option Shares”) at…”
+1 more passage from the same document
- “…Warrant has an initial exercise price per share of $0.00001, subject to certain adjustments. The Pre-Funded Warrants are…”
- 2026-05-05capital return (buybacks/dividends)recentOpen filing ↗“…the Offering, together with its existing cash, cash equivalents and marketable securities, to advance its clinical programs,…”
+1 more passage from the same document
- “…purposes. The Company intends to use approximately $39.0 million of the net proceeds from the Offering, to repurchase…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 344)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 1, 26SCHEDULE 13G ↗Passive stake · ForGrowth III PA B.V. · 5.1% · event on Sep 25, 26
- Aug 18, 26CORRESP ↗Correspondence with the SEC
- Aug 17, 26UPLOAD ↗Correspondence with the SEC
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Frazier Life Sciences Public Fund, L.P. · 5.6% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G ↗Passive stake · LONG FOCUS CAPITAL MANAGEMENT, LLC · 4.9% · event on Jun 30, 26
- Aug 12, 26SCHEDULE 13G/A ↗Passive stake · Adage Capital Management, L.P. · 8.4% · event on Jun 30, 26 · amendment
- Aug 11, 26S-3 ↗Securities offering
- Aug 11, 2610-Q ↗Quarterly report
- Aug 11, 268-K ↗Current report · Restructuring plan with committed costs
- Aug 5, 268-K ↗Current report · Shareholder vote results
- Jul 27, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 4.4% · event on Jun 30, 26 · amendment
- Jul 8, 26Form 4 ↗Insider transaction
- Jul 8, 26Form 3 ↗Insider transaction
- Jul 8, 268-K ↗Current report · A senior executive left or was appointed
- Jul 1, 26Form 4 ↗Insider transaction
- Jun 29, 26DEF 14A ↗Shareholder meeting and votes
- Jun 17, 26PRE 14A ↗Shareholder meeting and votes
344 filings on record, the oldest from Sep 10, 21.
Listing the 25 most recent filings of the 344 on record.
179
- Aug 11, 26Restructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
- Jul 8, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 5, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- May 4, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- May 4, 26A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- May 16, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
4 senior executive changes2024 – 2025show all 4hide
- May 15, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Apr 2, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 27, 24A senior executive left or was appointed8-K 5.02 ↗
- Apr 15, 24A senior executive left or was appointed8-K 5.02 ↗
- Nov 9, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 2, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 4, 23A senior executive left or was appointed8-K 5.02 ↗
- Dec 5, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- May 18, 22Entered a material agreement+1 more in the same filing8-K 1.01 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Matrix Capital Management Company LP11.2%May 16, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Chen Yu9.9%May 5, 26SCHEDULE 13G ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
- James N. Topper9.9%May 16, 25SCHEDULE 13G ↗20 co-filers on this document — the figure is the largest single stake, not their sum.
- Adage Capital Management, L.P.8.4%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Suvretta Capital Management, LLC7.6%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Frazier Life Sciences Public Fund, L.P.5.6%Jun 30, 26SCHEDULE 13G/A ↗14 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
show 4 more holdershide
- ForGrowth III PA B.V.5.1%Sep 25, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- LONG FOCUS CAPITAL MANAGEMENT, LLC4.9%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- BlackRock, Inc.4.4%Jun 30, 26SCHEDULE 13G/A ↗2 earlier filings
- Rajesh Parekh, Ph.D.3.3%Feb 13, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Jun 16, 26Sell$82KAnthony S GibneySee Remarks↗
- May 7, 26Sell$39.0MMatrix Capital Management Company, LP↗
- Apr 16, 26Sell$82KConor KilroySee Remarks↗
- Feb 17, 26Sell$241Klos Pinos Elisabet deSee Remarks↗
- Feb 17, 26Sell$43KAmy ElazzouziSenior Vice President, Finance↗
- Feb 17, 26Sell$103KJanet Jill HopkinsChief Medical Officer↗
- Feb 17, 26Sell$80KMark PlavsicChief Technology Officer↗
- Feb 17, 26Sell$61KConor KilroySee Remarks↗
- Jan 20, 26Sell$82Klos Pinos Elisabet deSee Remarks↗
- Jan 20, 26Sell$8KAmy ElazzouziSenior Vice President, Finance↗
- Nov 17, 25Sell$93KJanet Jill HopkinsChief Medical Officer↗
- Oct 29, 25Sell$57Klos Pinos Elisabet deSee Remarks↗
There are 2 more transactions in this stretch.
Stock compensation, tax and giftsshow the 26 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 1, 26Compensationamount n/aJulie PersonChief People Officer↗
- Sep 1, 26Compensationamount n/aJanet Jill HopkinsChief Medical Officer↗
- Sep 1, 26Compensationamount n/aAmy ElazzouziSVP, Finance & PAO↗
- Sep 1, 26Compensationamount n/aSusan Abu-AbsiChief Operating Officer↗
- Sep 1, 26Compensationamount n/aErica KratzChief Reg. & Quality Officer↗
- Jul 7, 26Compensationamount n/aJeremy Bender↗
- Jul 1, 26Compensationamount n/aConor KilroySee Remarks↗
- Jun 11, 26Compensationamount n/aAntony C. Mattessich↗
- Jun 11, 26Compensationamount n/aDavid Michael Johnson↗
- Jun 11, 26Compensationamount n/aSapna Srivastava↗
- Jun 11, 26Compensationamount n/aTeresa Marie Bitetti↗
- May 19, 26Compensationamount n/aNatalie C. HollesSee Remarks↗
- May 19, 26Compensationamount n/aNatalie C. HollesSee Remarks↗
- Mar 2, 26Compensationamount n/aAmy ElazzouziSenior Vice President, Finance↗
- Mar 2, 26Compensationamount n/aJanet Jill HopkinsChief Medical Officer↗
- Mar 2, 26Compensationamount n/aMark PlavsicChief Technology Officer↗
- Mar 2, 26Compensationamount n/alos Pinos Elisabet deSee Remarks↗
- Mar 2, 26Compensationamount n/aAnthony S GibneySee Remarks↗
- Mar 2, 26Compensationamount n/aConor KilroySee Remarks↗
- Aug 18, 25Compensation$13KAmy ElazzouziSenior Vice President, Finance↗
- Aug 18, 25Compensation$6KAmy ElazzouziSenior Vice President, Finance↗
- Aug 18, 25Compensation$3KAmy ElazzouziSenior Vice President, Finance↗
- Aug 18, 25Compensation$3KAmy ElazzouziSenior Vice President, Finance↗
- Aug 18, 25Compensation$13KAmy ElazzouziSenior Vice President, Finance↗
- Aug 18, 25Compensation$3KAmy ElazzouziSenior Vice President, Finance↗
- Aug 18, 25Compensation$10KAmy ElazzouziSenior Vice President, Finance↗
The full record holds 107 transactions and goes back to Jan 5, 23.
Its sector and its market
Aura Biosciences Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Aura Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Aura Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 344 documents on file, from Sep 10, 2021 to Oct 1, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.